Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 26–26 | Cite as

Alectinib

Interstitial lung disease: case report
Case report
  • 11 Downloads

Reference

  1. Yoshida H, et al. Efficacy of ceritinib after alectinib for ALK-positive non-small cell lung cancer. In Vivo 32: 1587-1590, No. 6, Dec 2018. Available from: URL: http://doi.org/10.21873/invivo.11418 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations